Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / OLFML2B

OLFML2B

Basics

Aliases:
This biomarker is also known as:
  • RP11-227F8.1,
  • photomedin-2,
  • olfactomedin-like protein 2B,
  • olfactomedin-like 2B,
  • DKFZP586L151,
  • Q68BL8,
  • Photomedin-2,

View in BioMuta

Description…

OLFML2B is a secreted protein. The gene is conserved across many species. The protein is a homodimer.

Attributes

QA State: Curated
Type: Protein
Short Name:
HGNC Name: OLFML2B

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Ovary

Attributes

Phase: One
QA State: Under Review

Overview

OLFML2B may be considered for further preclinical testing as a biomarker.

Performance Comment

OLFML2B has shown limited or no expression by qRT-PCR in normal tissues, but was expressed at high levels in ovarian cancer.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.